Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Virus Reactivation”

98 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 98 results

Post-approval studies (Phase 4)UnknownNCT01907230
What this trial is testing

Entecavir for Biological Agents Associated HBV Reactivation in Inflammatory Arthritis Patients

Who this might be right for
Rheumatoid ArthritisHepatitis B ReactivationExposure to Hepatitis B Virus
Taipei Veterans General Hospital, Taiwan 115
Not applicableNot Yet RecruitingNCT07703657
What this trial is testing

Controlled Trial of Prophylactic Rituximab to Reduce Clinically Significant EBV DNAemia After Allogeneic Hematopoietic Stem Cell Transplantation

Who this might be right for
Allogeneic Hematopoietic Stem Cell TransplantationEpstein-Barr Virus ReactivationClinically Significant EBV DNAemia
Yang Donglin 168
Not applicableStudy completedNCT02108444
What this trial is testing

Hepatitis B Virus Reactivation After Withdrawal of Prophylactic Antiviral Therapy in Lymphoma Patients

Who this might be right for
HepatitisHepatitis BLymphoma+1 more
Peking University 107
Post-approval studies (Phase 4)Study completedNCT01074645
What this trial is testing

Randomized Controlled Trial of Tenofovir in Patients of Reactivation of Hepatitis B Presenting as Acute on Chronic Liver Failure

Who this might be right for
Acute on Chronic Liver FailureHepatitis B
Govind Ballabh Pant Hospital 27
Large-scale testing (Phase 3)Study completedNCT01077908
What this trial is testing

Cytomegalovirus - Immunoprophylactic Adoptive Cellular Therapy Study

Who this might be right for
Cytomegalovirus Infection
Cell Medica Ltd 89
Not applicableStudy completedNCT02090803
What this trial is testing

Assessment of Human Herpes Virus Reactivation 6 Post Autologous Stem Cells

Who this might be right for
Hematologic Diseases
Institut de Cancérologie de la Loire 189
Not applicableNot Yet RecruitingNCT07210242
What this trial is testing

HCMV-miRNA Monitoring After Allogeneic Hematopoietic Stem Cell Transplantation Using PSTM-qPCR

Who this might be right for
Cytomegalovirus InfectionsHematopoietic Stem Cell TransplantationVirus Reactivation+1 more
Ting YANG 300
Testing effectiveness (Phase 2)Looking for participantsNCT06572462
What this trial is testing

ATG Individualized Dosing Model in URD-PBSCT.

Who this might be right for
Cytomegalovirus InfectionsInfection ReactivationStem Cell Transplant Complications
Chinese PLA General Hospital 30
Not applicableStudy completedNCT03511794
What this trial is testing

Effectiveness of the Hepatitis B Vaccine Post-Hematopoietic Stem Cell Transplant

Who this might be right for
Hepatitis B
National Heart, Lung, and Blood Institute (NHLBI) 52
Very early researchLooking for participantsNCT03665675
What this trial is testing

Donor Virus-Specific CMV or AdV CTL to Treat CMV or AdV Reactivation or Disease After Solid Organ or HCT

Who this might be right for
Allogeneic Hematopoietic Stem Cell Transplantation RecipientCytomegalovirusDonor+2 more
Sumithira Vasu 20
Not applicableLooking for participantsNCT06812598
What this trial is testing

Efficacy of Extended Letermovir Prophylaxis to Prevent CMV Reactivation in High-Risk Chinese Adults Undergoing Allogeneic HSCT

Who this might be right for
Cytomegalovirus InfectionsCMV
The First Affiliated Hospital of Soochow University 330
Not applicableStudy completedNCT01744587
What this trial is testing

Epstein-Barr Virus Reactivation and the Effect of EGCG on Virus Reactivation in Remission Patients

Who this might be right for
NPC
National Health Research Institutes, Taiwan 353
Not applicableEnded earlyNCT02843880
What this trial is testing

Prediction of Cytomegalovirus (CMV) Reactivation in Intensive Care Unit (ICU) by Immunological Study

Who this might be right for
CMV Infection
AdministrateurDRC 1
Not applicableUnknownNCT00720668
What this trial is testing

The Risk of Exacerbation of Chronic Hepatitis B After Percutaneous Radiofrequency Ablation of Hepatocellular Carcinoma

Who this might be right for
Hepatitis BHepatocellular Carcinoma
Sun Yat-sen University 200
Testing effectiveness (Phase 2)Looking for participantsNCT02532452
What this trial is testing

Third Party Viral Specific T-cells (VSTs)

Who this might be right for
Viral InfectionViral ReactivationInfection in an Immunocompromised Host
Children's Hospital Medical Center, Cincinnati 1,000
Not applicableNot Yet RecruitingNCT06364033
What this trial is testing

Biological and Clinical Efficacy of Shingrix in Patients With CLL

Who this might be right for
Chronic Lymphocytic LeukemiaSmall Lymphocytic LymphomaCLL-like MBL+1 more
Gruppo Italiano Malattie EMatologiche dell'Adulto 312
Post-approval studies (Phase 4)Study completedNCT00926757
What this trial is testing

Prophylactic Use of Entecavir for Non-Hodgkin's Lymphoma Patients With Resolved Hepatitis B

Who this might be right for
Non Hodgkin's LymphomaHepatitis B
Taipei Veterans General Hospital, Taiwan 80
Large-scale testing (Phase 3)Ended earlyNCT01694264
What this trial is testing

Study of Anti-Viral Prophylaxis for HBsAg(+) or HBcAb(+)/HBsAb(-) Patients Starting Anti-TNFα

Who this might be right for
Chronic Hepatitis BRheumatoid ArthritisAnkylosing Spondylitis+2 more
Seoul National University Hospital 43
Not applicableUnknownNCT05768061
What this trial is testing

HBV Reactivation in Anti CD20 Treatment

Who this might be right for
Hepatitis B
HaEmek Medical Center, Israel 5,000
Testing effectiveness (Phase 2)Study completedNCT02227641
What this trial is testing

Preventative/Preemptive Adoptive Transfer of Peptide Stimulated CMV/EBV Specific T-cells in Patients After Allogeneic Stem Cell Transplantation

Who this might be right for
Patients Undergoing Allogeneic Stem Cell Transplantation
University of Erlangen-Nürnberg Medical School 50
Next Page